Richard Pops serves as Alkermes’ Chairman and Chief Executive Officer. He joined Alkermes as CEO in 1991 and under his leadership, the organization has grown from a privately held company with 25 employees to an international, publicly-traded biopharmaceutical company with more than 2,000 employees.
Mr. Pops currently serves on the Board of Directors of Neurocrine Biosciences, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA).
Mr. Pops currently serves on the Board of Directors of Neurocrine Biosciences, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA).
Speaking In
10:00 AM - 10:45 AM (EST)
Tuesday, February 7
With the passage of the U.S. Inflation Reduction Act in August, biopharma companies must consider…
South Broadway Ballroom
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
